Swiss pharma firms are boosting investment in North Carolina as tariffs and tax breaks reshape production plans.
Raleigh, North Carolina has become an up and coming pharma hub in the US.
2023 Chansak Joe / Shutterstock.
Some 80 Swiss companies are based in the southeastern United States including Switzerland's two largest pharmaceutical firms - Roche and Novartis. The governor of North Carolina wants to attract even more.
This content was published on
August 11, 2026 - 09:00
Firmen aus dem Gesundheitssektor investieren wegen der Zölle so viel wie noch nie in den USA. Fabriken in der Schweiz drohen…
Swiss companies invested $27 billion in the US in early 2026 after tariffs dropped from 39% to 15%, with Roche and Novartis…
Pharma manufacturing in Switzerland appears to be unperturbed by the threat of tariffs but it might take several years before the…
The pharma industry is a mainstay of the Swiss economy and a global heavyweight. But the rise of new players could shake things…
Interpharma warns Switzerland may face a US Section 301 trade probe targeting drug pricing, threatening $35.5 billion in pharma…
AI, geopolitics, and new competitors are forcing Basel to fight harder for its place as a leading pharmaceutical hub.
